Get startedLog in
    Picture of D.Western Therapeutics Institute logo

    4576 — D.Western Therapeutics Institute Income Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for D.Western Therapeutics Institute, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue356414448428472
    Cost of Revenue
    Gross Profit339394421392425
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses6215868981,2571,745
    Operating Profit-266-172-450-829-1,273
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-290-160-440-827-1,289
    Provision for Income Taxes
    Net Income After Taxes-291-161-442-828-1,290
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-276-149-430-812-1,290
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-276-149-430-812-1,290
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-10.2-5.08-11.3-24.9-35.6
    Dividends per Share